105 related articles for article (PubMed ID: 37205500)
1. Evaluation of the Performance of the RECODe Equation with the Addition of Polygenic Risk Scores for Adverse Cardiovascular Outcomes in Individuals with Type II Diabetes.
Tsao NL; Judy R; Levin MG; Shakt G; ; ; Voight BF; Chen J; Damrauer SM
medRxiv; 2023 May; ():. PubMed ID: 37205500
[TBL] [Abstract][Full Text] [Related]
2. Genomic risk prediction of cardiovascular diseases among type 2 diabetes patients in the UK Biobank.
Ye Y; Hu J; Pang F; Cui C; Zhao H
Front Bioinform; 2023; 3():1320748. PubMed ID: 38239805
[No Abstract] [Full Text] [Related]
3. Assessing the performance of European-derived cardiometabolic polygenic risk scores in South-Asians and their interplay with family history.
Hassanin E; Maj C; Klinkhammer H; Krawitz P; May P; Bobbili DR
BMC Med Genomics; 2023 Jul; 16(1):164. PubMed ID: 37438803
[TBL] [Abstract][Full Text] [Related]
4. Combining European and U.S. risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study.
de La Harpe R; Thorball CW; Redin C; Fournier S; Müller O; Strambo D; Michel P; Vollenweider P; Marques-Vidal P; Fellay J; Vaucher J
Eur J Prev Cardiol; 2023 May; 30(7):561-571. PubMed ID: 36652418
[TBL] [Abstract][Full Text] [Related]
5. Evaluating cardiovascular disease risk stratification using multiple-polygenic risk scores and pooled cohort equations: insights from a 17-year longitudinal Korean cohort study.
Park YS; Jang HM; Park JH; Kim BJ; Park HY; Kim YJ
Front Genet; 2024; 15():1364993. PubMed ID: 38606355
[TBL] [Abstract][Full Text] [Related]
6. Derivation and Validation of Genome-Wide Polygenic Score for Ischemic Heart Failure.
Paranjpe I; Tsao NL; De Freitas JK; Judy R; Chaudhary K; Forrest IS; Jaladanki SK; Paranjpe M; Sharma P; ; ; Glicksberg BS; Narula J; Do R; Damrauer SM; Nadkarni GN
J Am Heart Assoc; 2021 Nov; 10(22):e021916. PubMed ID: 34713709
[TBL] [Abstract][Full Text] [Related]
7. Polygenic risk score improves the accuracy of a clinical risk score for coronary artery disease.
King A; Wu L; Deng HW; Shen H; Wu C
BMC Med; 2022 Nov; 20(1):385. PubMed ID: 36336692
[TBL] [Abstract][Full Text] [Related]
8. Integrating a Polygenic Risk Score for Coronary Artery Disease as a Risk-Enhancing Factor in the Pooled Cohort Equation: A Cost-Effectiveness Analysis Study.
Mujwara D; Henno G; Vernon ST; Peng S; Di Domenico P; Schroeder B; Busby GB; Figtree GA; Bottà G
J Am Heart Assoc; 2022 Jun; 11(12):e025236. PubMed ID: 35699184
[TBL] [Abstract][Full Text] [Related]
9. Polygenic risk score adds to a clinical risk score in the prediction of cardiovascular disease in a clinical setting.
Samani NJ; Beeston E; Greengrass C; Riveros-McKay F; Debiec R; Lawday D; Wang Q; Budgeon CA; Braund PS; Bramley R; Kharodia S; Newton M; Marshall A; Krzeminski A; Zafar A; Chahal A; Heer A; Khunti K; Joshi N; Lakhani M; Farooqi A; Plagnol V; Donnelly P; Weale ME; Nelson CP
Eur Heart J; 2024 Jun; ():. PubMed ID: 38848106
[TBL] [Abstract][Full Text] [Related]
10. A novel polygenic risk score improves prognostic prediction of heart failure with preserved ejection fraction in the Chinese Han population.
Han Y; Lu J; Chen B; Li X; Dai H; Zhang L; Yan X; Liu J; Zhang H; Fu X; Yu Q; Ren J; Cui H; Gao Y; Li J
Eur J Prev Cardiol; 2023 Sep; 30(13):1382-1390. PubMed ID: 37343143
[TBL] [Abstract][Full Text] [Related]
11. Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.
Damask A; Steg PG; Schwartz GG; Szarek M; Hagström E; Badimon L; Chapman MJ; Boileau C; Tsimikas S; Ginsberg HN; Banerjee P; Manvelian G; Pordy R; Hess S; Overton JD; Lotta LA; Yancopoulos GD; Abecasis GR; Baras A; Paulding C;
Circulation; 2020 Feb; 141(8):624-636. PubMed ID: 31707832
[TBL] [Abstract][Full Text] [Related]
12. An Improved Genome-Wide Polygenic Score Model for Predicting the Risk of Type 2 Diabetes.
Liu W; Zhuang Z; Wang W; Huang T; Liu Z
Front Genet; 2021; 12():632385. PubMed ID: 33643391
[TBL] [Abstract][Full Text] [Related]
13. Risk prediction and interaction analysis using polygenic risk score of type 2 diabetes in a Korean population.
Song M; Kwak SH; Kim J
Sci Rep; 2024 Mar; 14(1):6790. PubMed ID: 38514700
[TBL] [Abstract][Full Text] [Related]
14. Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study.
Khawaja T; Linge J; Leinhard OD; Al-Kindi SG; Rajagopalan S; Khera A; de Lemos JA; Joshi P; Neeland IJ
Prog Cardiovasc Dis; 2023; 78():67-73. PubMed ID: 36931545
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease risk prediction using automated machine learning: A prospective study of 423,604 UK Biobank participants.
Alaa AM; Bolton T; Di Angelantonio E; Rudd JHF; van der Schaar M
PLoS One; 2019; 14(5):e0213653. PubMed ID: 31091238
[TBL] [Abstract][Full Text] [Related]
16. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
Elife; 2023 Mar; 12():. PubMed ID: 36971353
[TBL] [Abstract][Full Text] [Related]
17. Incorporating a polygenic risk score-triaged coronary calcium score into cardiovascular disease examinations to identify subclinical coronary artery disease (ESCALATE): Protocol for a prospective, nonrandomized implementation trial.
Gray MP; Berman Y; Bottà G; Grieve SM; Ho A; Hu J; Hyun K; Ingles J; Jennings G; Kilov G; Levesque JF; Meikle P; Redfern J; Usherwood T; Vernon ST; Nicholls SJ; Figtree GA;
Am Heart J; 2023 Oct; 264():163-173. PubMed ID: 37364748
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of using polygenic risk score to guide risk screening and interventions for the prevention of type 2 diabetes in individuals with high overall baseline risk.
Martikainen J; Lehtimäki AV; Jalkanen K; Lavikainen P; Paajanen T; Marjonen H; Kristiansson K; Lindström J; Perola M
Front Genet; 2022; 13():880799. PubMed ID: 36186460
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide polygenic risk score for type 2 diabetes in Indian population.
Pemmasani SK; Atmakuri S; Acharya A
Sci Rep; 2023 Jul; 13(1):11568. PubMed ID: 37463971
[TBL] [Abstract][Full Text] [Related]
20. How Do We Incorporate Polygenic Risk Scores in Cardiovascular Disease Risk Assessment and Management?
Hadley TD; Agha AM; Ballantyne CM
Curr Atheroscler Rep; 2021 Apr; 23(6):28. PubMed ID: 33791884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
